National Research Corporation (NASDAQ:NRCI) today announced results for
the first quarter 2011.
-
Quarterly revenue up 14% to $19.8 million
-
Quarterly net income up 10% to $3.5 million
-
Quarterly diluted earnings per share of $0.51, up 9%
-
Total Contract Value reaches $76.6 million, up 24%
Commenting on the first quarter results, Michael D. Hays, president and
chief executive officer of National Research Corporation, said, "Against
a strong comparable quarter in 2010, our first quarter of 2011 was very
rewarding and set a number of records. We continue to achieve large
increases in new sales as a result of the compelling value proposition
of our subscription-based offerings, supported by investments made to
expand our sales force. Our sales growth is also attributed to the
Company’s unique position with a clear differentiated portfolio that
directly meets the industry need, driven by healthcare reform, for
cross-continuum expertise.
Revenue for the quarter ended March 31, 2011, was $19.8 million,
compared to $17.4 million for the same quarter in 2010. Net income for
the quarter ended March 31, 2011, was $3.5 million, or $.52 per basic
and $.51 per diluted share, compared to $3.1 million for the first
quarter 2010, or $0.47 per basic and diluted share.
In closing, Patrick E. Beans, chief financial officer of National
Research Corporation, said, "As evidenced by our sales traction,
subscription-based offerings are finding great market acceptance, even
though such contracts often push revenue to outlying periods.”
A listen-only simulcast of National Research Corporation’s 2011 first
quarter conference call will be available online at www.earnings.com
on May 4, 2011, beginning at 11:00 a.m. Eastern time. The online replay
will follow approximately one hour later and continue for 30 days.
National Research Corporation, headquartered in Lincoln, Nebraska, is a
leading provider of performance measurement, improvement services, and
governance education to the healthcare industry in the United States and
Canada.
This press release includes "forward-looking” statements related to
the Company that can generally be identified as describing the Company’s
future plans, objectives or goals.
Such forward-looking
statements are subject to risks and uncertainties that could cause
actual results or outcomes to differ materially from those currently
anticipated.
These forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995.
For further information about the factors
that could affect the Company’s future results, please see the Company’s
filings with the Securities and Exchange Commission.
|
NATIONAL RESEARCH CORPORATION
|
|
Unaudited Consolidated Statements of Operations
|
|
(In thousands, except per share data)
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2011
|
|
|
2010
|
|
|
|
|
Revenue
|
|
$
|
19,791
|
|
|
$
|
17,370
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
Direct expenses
|
|
|
6,758
|
|
|
|
6,456
|
|
|
Selling, general and administrative
|
|
|
6,090
|
|
|
|
4,469
|
|
|
Depreciation and amortization
|
|
|
1,243
|
|
|
|
1,098
|
|
|
Total operating expenses
|
|
|
14,091
|
|
|
|
12,023
|
|
|
|
|
Operating income
|
|
|
5,700
|
|
|
|
5,347
|
|
|
|
|
Other income (expense), net:
|
|
|
|
|
|
Interest income
|
|
2
|
|
|
1
|
|
|
Interest expense
|
|
|
(169
|
)
|
|
|
(98
|
)
|
|
Other, net
|
|
|
(29
|
)
|
|
|
(43
|
)
|
|
|
|
Total other income (expense), net
|
|
|
(196
|
)
|
|
|
(140
|
)
|
|
|
|
Income before income taxes
|
|
|
5,504
|
|
|
|
5,207
|
|
|
Provision for income taxes
|
|
|
2,048
|
|
|
|
2,079
|
|
|
|
|
Net income
|
|
$
|
3,456
|
|
|
$
|
3,128
|
|
|
|
|
Net income per share, basic
|
|
$
|
0.52
|
|
|
$
|
0.47
|
|
|
Net income per share, diluted
|
|
$
|
0.51
|
|
|
$
|
0.47
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
Basic
|
|
|
6,654
|
|
|
|
6,640
|
|
|
Diluted
|
|
|
6,809
|
|
|
|
6,711
|
|
|
|
|
|
|
|
|
|
|
NATIONAL RESEARCH CORPORATION
|
|
Unaudited Consolidated Condensed Balance Sheets
|
|
(Dollars in thousands)
|
|
|
|
|
|
March. 31,
|
|
Dec. 31,
|
|
|
|
2011
|
|
2010
|
|
ASSETS
|
|
|
|
|
|
|
|
Current Assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
3,316
|
|
|
$
|
3,519
|
|
|
Accounts receivable, net
|
|
|
12,925
|
|
|
|
9,172
|
|
|
Income taxes recoverable
|
|
|
713
|
|
|
|
1,277
|
|
|
Other current assets
|
|
|
3,432
|
|
|
|
3,373
|
|
|
Total current assets
|
|
|
20,386
|
|
|
|
17,341
|
|
|
|
|
Net property and equipment
|
|
|
14,227
|
|
|
|
14,482
|
|
|
Other, net
|
|
|
63,595
|
|
|
|
63,947
|
|
|
|
|
Total Assets
|
|
$
|
98,208
|
|
|
$
|
95,770
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
Current Liabilities:
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$
|
2,599
|
|
|
$
|
3,872
|
|
|
Deferred revenue
|
|
|
18,759
|
|
|
|
17,701
|
|
|
Accrued compensation
|
|
|
2,526
|
|
|
|
2,750
|
|
|
Notes payable
|
|
|
1,843
|
|
|
|
1,827
|
|
|
Total current liabilities
|
|
|
25,727
|
|
|
|
26,150
|
|
|
|
|
Non-current liabilities
|
|
|
21,345
|
|
|
|
21,036
|
|
|
|
|
Total Liabilities
|
|
|
47,072
|
|
|
|
47,186
|
|
|
|
|
Shareholders’ Equity:
|
|
|
|
|
|
Common stock, $0.001 par value; 20,000,000 shares authorized;
|
|
|
|
|
|
issued 8,091,985 in 2011 and 8,044,855 in 2010;
|
|
|
|
|
|
outstanding 6,713,407 in 2011 and 6,668,574 in 2010
|
|
8
|
|
|
8
|
|
|
Additional paid-in capital
|
|
|
29,392
|
|
|
|
28,970
|
|
|
Retained earnings
|
|
|
43,322
|
|
|
|
41,343
|
|
|
Accumulated other comprehensive income
|
|
|
1,333
|
|
|
|
1,108
|
|
|
Treasury stock
|
|
|
(22,919
|
)
|
|
|
(22,845
|
)
|
|
Total shareholders’ equity
|
|
|
51,136
|
|
|
|
48,584
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
98,208
|
|
|
$
|
95,770
|
|
